The new biochip called the Transfected Enzyme and Metabolism Chip or TeamChip technology “is a good way to determine, very early on, both the efficacy and the potential toxicity of a drug candidate.” —Jonathan Dordick
“A new protein engineering technique enables researchers to create potent, uniform inhibitors of anthrax toxin. We can now systematically control...properties, and tune them to influence the activity of the inhibitor molecules.” —Ravi Kane
Through a broad network of research centers, Rensselaer researchers are creating new routes to drug discovery and development, understanding the fundamental mechanisms of disease, as well as examining mechanisms for enabling affordable health care technologies and improving human health.
Therapeutic Intervention in Alzheimer’s Research
Rensselaer researchers have followed the trail of two genetic mutations to uncover how they lead to biochemical changes that are associated with Familial Alzheimer's, while a researcher in the LRC has used lighting to help seniors avoid falls during the night. Full Story
Drug Discovery and High-Throughput Screening A team of researchers has developed a type of biochip that could enable pharmaceutical companies to start doing quick, reliable, high-throughput toxicity testing significantly earlier in the process of the testing of drug candidates. Full Story
Regenerative Medicine Research is being carried out on developing new surgical tools and techniques for cutting and drilling bone that take into account both the age of individual patients as well as the particular microstructure of their bone, which could lead to faster recovery times and fewer revision surgeries for patients. Full Story